Recent studies in erythroid cells have shown that autophagy is an important process for the physiological clearance of mitochondria during terminal differentiation. However, autophagy also plays an important role in removing damaged and dysfunctional mitochondria. Defective mitochondria and impaired erythroid maturation are important characteristics of low-risk myelodysplasia. In this study we therefore questioned whether the autophagic clearance of mitochondria might be altered in erythroblasts from patients with refractory anemia (RA, n ¼ 3) and RA with ringed sideroblasts (RARS, n ¼ 6). Ultrastructurally, abnormal and iron-laden mitochondria were abundant, especially in RARS patients. A large proportion (52±16%) of immature and mature myelodysplastic syndrome (MDS) erythroblasts contained cytoplasmic vacuoles, partly double membraned and positive for lysosomal marker LAMP-2 and mitochondrial markers, findings compatible with autophagic removal of dysfunctional mitochondria. In healthy controls only mature erythroblasts comprised these vacuoles (12 ± 3%). These findings were confirmed morphometrically showing an increased vacuolar surface in MDS erythroblasts compared to controls (Po0.0001). In summary, these data indicate that MDS erythroblasts show features of enhanced autophagy at an earlier stage of erythroid differentiation than in normal controls. The enhanced autophagy might be a cell protective mechanism to remove defective iron-laden mitochondria.
Introduction
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal stem cell disorders characterized by an ineffective and dysplastic hematopoiesis. Especially in low-risk MDS, such as refractory anemia (RA) and RA with ringed sideroblasts (RARS), increased programmed cell death of bone marrow hematopoietic cells has been described. This might be an important mechanism to explain the typical clinical findings of a hypercellular bone marrow and peripheral blood cytopenias. In particular, enhanced apoptosis has been reported in low-risk MDS. 1, 2 In erythroid precursors from RARS patients this process was associated with loss of mitochondrial transmembrane potential, mitochondrial release of cytochrome c and subsequent activation of caspase-9 and caspase-3. These events might be initiated by mitochondrial dysfunction owing to accumulation of reactive oxygen species (ROS) resulting from aberrant iron mitochondrial distribution in ringed sideroblasts. 3 Loss of mitochondrial transmembrane potential can also induce autophagy, a natural degradative process in which cytoplasmic material, including organelles and macromolecules, is segregated into double-membraned vesicles (autophagosomes), which are subsequently degraded in a lysosomal dependent manner. 4 During terminal differentiation erythroid cells undergo enucleation and removal of organelles. Recently, it was shown that mitochondria are eliminated from these cells by autophagy and that sequestration of mitochondria in autophagosomes is induced by the loss of mitochondrial membrane potential. 5 To investigate whether this process is altered in MDS erythroid precursors, ultrastructural, cytomorphometric and immunohistochemical studies for autophagic markers were performed on bone marrow erythroid precursors. The results show that MDS erythroid cells demonstrate features of enhanced autophagy, which is already present early in the differentiation process.
Materials and methods

Patients
Bone marrow of low-risk MDS patients (n ¼ 9) and healthy controls (n ¼ 4) was aspirated from the iliac crest. The diagnosis of MDS was made according to the World Health Organization classification. 6 The international prognostic scoring system was used to define prognostic risk. 7 Transfusion dependency was defined the need for one or more units of red blood cells per month. The institutional review board of the University Hospital Groningen approved the study protocol. All patients gave informed consent.
Immunohistochemistry LC3 staining. For immunohistochemical staining, serial 3-mm-thick sections were cut from paraffin-embedded bone marrow biopsies and mounted on aminopropyl-ethoxy-silan (APES; Sigma-Aldrich, Diesenhofen, Germany)-coated glass slides. After deparaffinization in xylene, antigen retrieval was performed using microwave heating at 700 W for 10 min in EDTA (ethylenediaminetetraacetic acid) buffer. Following blocking of endogenous peroxidase with 0.5% hydrogen peroxide for 20 min, the primary antibody was applied for 1 h at room temperature. To identify microtubule-associated protein 1 light chain 3 (LC3), immunostaining with a rabbit polyclonal antibody (1:200; MBL, Nagoya, Japan) was used. After washing with phosphate-buffered saline (PBS) slides were incubated for 1 h at 37 1C with goat anti-rabbit-biotinylated antibody (GARBIO; DAKO, Glostrup, Denmark; 1:300). The sections were incubated in Vectastain Elite ABC-kit PK-6100 (Vector Laboratories Inc., Burlingame, CA, USA) for 1 h at room temperature and the peroxidase was visualized with diaminobenzidine yielding a brown reaction product. Sections were counterstained with hematoxylin. Positive control was kidney tissue; negative control, replacement of the primary antibody with PBS.
Evaluation of the staining pattern was performed by light microscopy. Slides were evaluated by at least two independent investigators who did not have knowledge of the clinical data. If the evaluations did not agree, they were reevaluated under a multiheaded microscope. Samples were scored semiquantitatively (0, no staining; 1, weak; 2, distinct; 3, strong); only distinct and strong cytoplasmic or membrane-bound staining (scores 2 and 3) was regarded as positive. In cases of heterogeneous staining the most representative parts of the sample were investigated.
Activated caspase-3. To identify activated caspase-3 in erythroblasts from bone marrow biopsy samples, immunostaining with a rabbit polyclonal antibody (1:100; New England Biolabs, Beverly, MA, USA) was used as previously described. 8 Samples were scored as negative (that is, absence of detectable cytoplasmic staining) or positive. A total of 100 erythroblasts per sample were examined.
Electron microscopy Bone marrow sample preparation. Immunogold labeling. Bone marrow mononuclear cells were fixed in 4% paraformaldehyde and 0.1% glutaraldehyde, pH 7.4 at 4 1C for 30 min. For cryosectioning, bone marrow samples were embedded in 5% gelatin and frozen in liquid nitrogen. Thin sections (80 nm) were cut at À100 1C for immunoelectron microscopy. Cryosections were picked up in a 2.3 M saturated sucrose solution. The sections were then labeled with polyclonal goat anti-lysosome-associated membrane protein (LAMP)-2 (Santa Cruz Biotechnology, Heidelberg, Germany), polyclonal rabbit anti-LC3 (MBL), mouse anti-mitochondrial inner membrane (H6/C12) antigen (Santa Cruz Biotechnology) and mouse anti-cytochrome c (Santa Cruz Biotechnology), which were detected with rabbit anti-goatimmunoglobulin G (IgG) 5 nm gold for LAMP-2, goat anti-rabbit IgG 10 nm for LC3, goat anti-mouse IgG 10 nm for cytochrome c and mitochondrial inner membrane and goat anti-rabbit IgG 10 nm. Double labelings were done by mixing the primary antibodies from different species and the corresponding secondary antibodies conjugated with different sized gold particles. Sections were mounted in 1.5% methylcellulose containing 0.4% uranyl acetate and examined in detail with electron microscopy (Philips 201; Philips).
Ultrastructural definitions of autophagy. Autophagy was defined according to the recent recommendations of the Nomenclature Committee on Cell Death on the classification of cell death. 9 Autophagy is a distinct morphologic entity. The presence of cytoplasmic double-membraned vacuoles containing degenerating cytoplasmic organelles or cytosol was essential for the definition of autophagy. Autolysosomes were defined by electron microscopy as vacuoles containing both molecular markers of lysosomes (LAMP-2) and molecular markers of organelles (mitochondria) or morphological remnants of organelles (iron deposits were considered as mitochondrial remnants). Apoptosis was also defined following recommendations of the before mentioned committee. 
Statistical analysis
Data are reported as mean±standard deviation and as median (range). Statistical analysis was performed using the unpaired t-test and the Mann Whitney test. 
Results
The ultrastructural studies of erythroid cells in all patients (n ¼ 9; see Table 1 ) demonstrated that in a significantly higher fraction of erythroblasts cytoplasmic vacuolization was present (52 ± 16 vs 12 ± 3% of the erythroblasts in healthy controls, P ¼ 0.003).
Vacuoles were present in all stages of MDS erythroblasts, whereas in the normal counterparts only terminally differentiated erythroblasts demonstrated these vacuoles. A median of 13% (range 2-25) of the vacuoles in MDS erythroblasts were double membraned compared to 2% (range 0-4) in normal control erythroblasts. Double-membrane vacuoles are a main characteristic of autophagosomes (Figure 1 ). To further underscore that the cytoplasmic vacuoles are autophagosomes immunogold labeling for LC3 was performed which is present on autophagic membranes. 9 LC3 could be demonstrated on membranes and inside the majority of the vacuoles in the MDS erythroid cells (Figure 2) . Similarly, immunohistochemistry of bone marrow biopsies for LC3 staining showed a positive punctuate staining in erythroblasts from MDS patients (n ¼ 5) compared to a weak staining intensity in healthy controls (n ¼ 4; Figure 3 ). The staining intensity in MDS patients varied between distinct (n ¼ 1) and strong (n ¼ 4).
The late step in autophagy involves the formation of autolysosomes by the fusion of autophagosomes and lysosomes. Therefore, immunogold double labeling was performed for molecular markers of lysosomes (LAMP-2) and organelles that may be present in autophagosomes, including mitochondria. Detection of mitochondria or remnants of mitochondria can be assessed with an antibody against a mitochondrial inner membrane antigen and cytochrome c. Immunogold labeling for LAMP-2 and cytochrome c demonstrated that both were present and colocalized in the vacuoles (Figure 4a ) In addition, colocalization of LAMP-2 and the mitochondrial inner membrane antigen and iron deposits was demonstrated in vacuoles ( Figure 4b) . Therefore, we concluded that an enhanced autophagic process is present in MDS erythroid cells.
Iron-laden mitochondria were present in a large percentage of erythroblasts of all patients (MDS vs healthy controls: 37±19 vs 0%, P ¼ 0.03). This fraction was higher in patients with RARS than with RA (48±14 vs 19±7%, P ¼ 0.04). More than 50% of these iron-laden mitochondria were abnormally shaped mitochondria, especially in patients with RARS. As expected, the mitochondrial inner membrane antigen and cytochrome c were present in mitochondria. Cytochrome c was also present in moderate amounts in the cytoplasm, suggesting that a fraction of the MDS mitochondria were defective and undergoing mitochondrial outer membrane permeabilization.
As indicated, the presence of vacuoles was not restricted to MDS erythroblasts. Also in normal erythroblasts vacuoles were present, but only in mature erythroblasts of stage III. These vacuoles contained LAMP-2, cytochrome c and the mitochondrial inner membrane antigen, underscoring that autophagy Enhanced mitochondrial autophagy in low-risk MDS EJ Houwerzijl et al occurs at a later time point in the normal erythroid differentiation program (Figure 4c ). Characteristics of apoptosis such as chromatin condensation, nuclear fragmentation and plasma membrane blebbing, were found in a low percentage of MDS erythroid cells (2 ± 2%, median 2%, range 0-6%) compared to the complete absence of apoptotic erythroblasts in healthy controls (n ¼ 4). Immunohistochemical staining for activated caspase-3 of fresh bone marrow biopsies (n ¼ 8) showed similar percentages of positive erythroblasts (median 2%, range 1-3%), making loss of apoptotic cells during specimen processing for electron microscopy very unlikely.
To quantify the observed morphological differences between normal and MDS erythroid cells, morphometry of these cells was performed. No differences were observed in cell volume, the ratio of the area of mitochondria/cytoplasm. However, the ratio area of vacuoles/cytoplasm in stages II and III erythroblasts was significant higher in MDS samples (stage I, 0.001 vs 0.0048 (P ¼ 0.17); stage II, 0.002 vs 0.011 (Po0.0001); stage III, 0.003 Figure 3 Microtubule-associated protein 1 light chain 3 (LC3 staining of myelodysplastic syndrome (MDS) and normal bone marrow. Immunohistochemical staining of bone marrow biopsies for LC3 shows that autophagic vacuoles are distinctly more prevalent in bone marrow cells from MDS patients (n ¼ 5; a) compared to healthy controls (n ¼ 4; b). 
Discussion
This study demonstrates that in MDS erythroid progenitors the level of mitochondrial autophagy is increased and occurs at an earlier time point in the differentiation process compared to normal erythroid cells. Ultrastructural examination demonstrated an approximately five times increase in the number of cytoplasmic vacuoles in low-risk MDS erythroblasts compared to healthy controls. A proportion of these vacuoles were double membraned. Immunogold labeling for LC3 further confirmed the autophagic nature of the vacuoles. The localization of LAMP-2 revealed that lysosomal structures were present in the vacuoles. Moreover, the majority of lysosomal structures contained endogenous mitochondrial proteins or iron deposits, indicative for enhanced autophagic degradation of mitochondria.
Autophagy is described to be involved in several cellular recycling processes. A low basal level of constitutive autophagy is critical for clearance of misfolded proteins. In addition, by producing amino acids that support ATP generation necessary for maintaining cell viability, autophagy functions as a physiologic cytoprotective response to nutrient and/or growth factor depletion. However, autophagy is also linked to cell death. [10] [11] [12] [13] In normal erythropoiesis autophagy is present during the process of enucleation. At this stage the autophagic process contributes to the removal of mitochondria.
14 In rat studies, autophagosomes occupied 0.2% of the cytoplasm of differentiated erythroblasts, 15 which is consistent with the results of this study. In MDS erythroblasts, however, this fraction is approximately five times higher. Moreover, the autophagic vacuoles were not only present in mature, but also in immature erythroblasts, indicating that mitochondrial autophagy in MDS is more pronounced and occurs earlier in the differentiation program. A recent study of Tehranchi et al. 3 
demonstrated that MDS CD34
þ cells have an enhanced expression of genes encoding for the erythroid lineage. Intrinsic defects in the programming of erythroid differentiation might be responsible for the early initiation of the autophagic process. Alternatively, the early initiation of mitochondrial autophagy might be related to the increased number of dysfunctional and iron-laden mitochondria noticed in MDS. Several studies [16] [17] [18] [19] [20] have demonstrated that mitochondrial dysfunction exists in MDS, which may result in increased oxidative stress, an impaired cellular ATP production, and an increased release of apoptosisinducing factors in the cytoplasm. 21, 22 An animal model of mitochondrial dysfunction generating macrocytic anemia and myelodysplastic bone marrow morphology has also recently been described. 23, 24 Furthermore, Tehranchi et al. showed that the aberrant mitochondrial iron distribution in RARS erythroblasts occurred at a very early stage of erythroid differentiation, suggesting that the mitochondrial dysfunction is an early event. The present data show that these damaged and dysfunctional mitochondria are degraded by autophagy probably as a protective mechanism to restore the cellular bioenergetic state and decrease ROS accumulation. A recent in vitro study demonstrated that this repair mechanism is in particular operational if caspase activation is blocked and if glycolysis is elevated as a result of sustained levels of glyceraldehyde-3-phosphate dehydrogenase. 25 Cells subsequently survived, even though mitochondrial outer membrane permeabilization and cytochrome c release was present. These findings as well as the fact that we used fresh patient material might explain why we predominantly observed autophagic erythroblasts and limited apoptosis.
In summary, these data indicate that MDS erythroblasts show features of enhanced mitochondrial autophagy at an earlier stage of the erythroid differentiation. The enhanced autophagy might be considered as a cell protective mechanism to remove defectively formed and iron-laden mitochondria, but might also have consequences for the erythroid differentiation program. Enhanced mitochondrial autophagy in low-risk MDS EJ Houwerzijl et al
